MEI Net Income vs Income Tax Expense Analysis

MEIP Stock

USD 2.43 0.03 1.22%

MEI Pharma financial indicator trend analysis is infinitely more than just investigating MEI Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MEI Pharma is a good investment. Please check the relationship between MEI Pharma Net Income and its Income Tax Expense accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEI Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.

Net Income vs Income Tax Expense

Net Income vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MEI Pharma Net Income account and Income Tax Expense. At this time, the significance of the direction appears to have strong relationship.

The correlation between MEI Pharma's Net Income and Income Tax Expense is 0.7. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of MEI Pharma, assuming nothing else is changed. The correlation between historical values of MEI Pharma's Net Income and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of MEI Pharma are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Net Income i.e., MEI Pharma's Net Income and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

0.7

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in MEI Pharma financial statement analysis. It represents the amount of money remaining after all of MEI Pharma operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Income Tax Expense

Most indicators from MEI Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MEI Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEI Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.At this time, MEI Pharma's Selling General Administrative is relatively stable compared to the past year. As of 03/05/2025, Enterprise Value Over EBITDA is likely to grow to 0.55, while Sales General And Administrative To Revenue is likely to drop 0.39.

MEI Pharma fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Retained Earnings	Short Term Investments	Short Long Term Debt Total	Non Current Liabilities Total	Property Plant And Equipment Net	Non Current Assets Total	Property Plant And Equipment Gross	Property Plant Equipment	Net Tangible Assets	Good Will	Retained Earnings Total Equity	Capital Surpluse	Intangible Assets
Total Assets		0.73	0.92	0.65	0.22	0.71	0.09	1.0	0.46	0.7	0.52	0.96	1.0	-0.57	0.98	0.09	0.95	0.62	0.62	0.58	0.21	0.65	0.12	-0.65	0.66	0.12
Other Current Liab	0.73		0.84	0.32	0.48	0.87	-0.06	0.7	0.74	0.92	0.76	0.76	0.7	-0.86	0.7	0.48	0.72	0.85	0.85	0.88	0.62	0.29	0.13	-0.84	0.84	0.13
Total Current Liabilities	0.92	0.84		0.42	0.44	0.85	-0.08	0.9	0.63	0.77	0.62	0.95	0.9	-0.71	0.91	0.21	0.92	0.77	0.76	0.75	0.43	0.41	0.0	-0.78	0.76	0.0
Total Stockholder Equity	0.65	0.32	0.42		-0.2	0.2	0.18	0.68	0.15	0.18	0.31	0.42	0.68	-0.27	0.63	0.05	0.41	-0.03	-0.02	-0.06	-0.16	0.96	0.58	-0.3	0.44	0.58
Net Debt	0.22	0.48	0.44	-0.2		0.48	-0.86	0.19	0.59	0.38	0.51	0.31	0.2	-0.55	0.34	0.33	0.27	0.4	0.37	0.46	0.57	-0.19	-0.49	-0.6	0.51	-0.49
Accounts Payable	0.71	0.87	0.85	0.2	0.48		-0.08	0.69	0.68	0.77	0.67	0.77	0.68	-0.78	0.69	0.35	0.74	0.82	0.81	0.83	0.57	0.18	-0.01	-0.79	0.77	-0.01
Cash	0.09	-0.06	-0.08	0.18	-0.86	-0.08		0.1	-0.41	0.06	-0.34	0.07	0.08	0.29	-0.08	-0.28	0.1	0.12	0.15	0.04	-0.38	0.18	0.46	0.35	-0.28	0.46
Cash And Short Term Investments	1.0	0.7	0.9	0.68	0.19	0.69	0.1		0.44	0.66	0.5	0.95	1.0	-0.56	0.98	0.08	0.94	0.59	0.59	0.54	0.18	0.68	0.15	-0.63	0.65	0.15
Common Stock Shares Outstanding	0.46	0.74	0.63	0.15	0.59	0.68	-0.41	0.44		0.63	0.97	0.45	0.44	-0.95	0.52	0.8	0.4	0.5	0.49	0.63	0.93	0.18	0.11	-0.95	0.87	0.11
Other Current Assets	0.7	0.92	0.77	0.18	0.38	0.77	0.06	0.66	0.63		0.62	0.77	0.66	-0.74	0.65	0.37	0.75	0.87	0.86	0.88	0.53	0.18	-0.03	-0.71	0.69	-0.03
Other Stockholder Equity	0.52	0.76	0.62	0.31	0.51	0.67	-0.34	0.5	0.97	0.62		0.46	0.5	-0.96	0.57	0.85	0.41	0.47	0.45	0.58	0.86	0.34	0.27	-0.95	0.89	0.27
Total Liab	0.96	0.76	0.95	0.42	0.31	0.77	0.07	0.95	0.45	0.77	0.46		0.95	-0.56	0.93	0.03	1.0	0.75	0.75	0.71	0.26	0.42	-0.08	-0.63	0.62	-0.08
Total Current Assets	1.0	0.7	0.9	0.68	0.2	0.68	0.08	1.0	0.44	0.66	0.5	0.95		-0.55	0.98	0.07	0.94	0.57	0.57	0.53	0.18	0.68	0.13	-0.63	0.65	0.13
Retained Earnings	-0.57	-0.86	-0.71	-0.27	-0.55	-0.78	0.29	-0.56	-0.95	-0.74	-0.96	-0.56	-0.55		-0.6	-0.77	-0.52	-0.61	-0.6	-0.7	-0.84	-0.26	-0.18	0.98	-0.93	-0.18
Short Term Investments	0.98	0.7	0.91	0.63	0.34	0.69	-0.08	0.98	0.52	0.65	0.57	0.93	0.98	-0.6		0.13	0.92	0.56	0.56	0.54	0.27	0.65	0.06	-0.7	0.68	0.06
Short Long Term Debt Total	0.09	0.48	0.21	0.05	0.33	0.35	-0.28	0.08	0.8	0.37	0.85	0.03	0.07	-0.77	0.13		-0.01	0.21	0.2	0.36	0.81	0.11	0.35	-0.68	0.62	0.35
Non Current Liabilities Total	0.95	0.72	0.92	0.41	0.27	0.74	0.1	0.94	0.4	0.75	0.41	1.0	0.94	-0.52	0.92	-0.01		0.74	0.73	0.69	0.21	0.41	-0.1	-0.59	0.58	-0.1
Property Plant And Equipment Net	0.62	0.85	0.77	-0.03	0.4	0.82	0.12	0.59	0.5	0.87	0.47	0.75	0.57	-0.61	0.56	0.21	0.74		1.0	0.98	0.51	-0.01	-0.08	-0.6	0.54	-0.08
Non Current Assets Total	0.62	0.85	0.76	-0.02	0.37	0.81	0.15	0.59	0.49	0.86	0.45	0.75	0.57	-0.6	0.56	0.2	0.73	1.0		0.98	0.49	0.0	-0.05	-0.59	0.53	-0.05
Property Plant And Equipment Gross	0.58	0.88	0.75	-0.06	0.46	0.83	0.04	0.54	0.63	0.88	0.58	0.71	0.53	-0.7	0.54	0.36	0.69	0.98	0.98		0.65	-0.04	-0.06	-0.69	0.61	-0.06
Property Plant Equipment	0.21	0.62	0.43	-0.16	0.57	0.57	-0.38	0.18	0.93	0.53	0.86	0.26	0.18	-0.84	0.27	0.81	0.21	0.51	0.49	0.65		-0.13	0.03	-0.81	0.7	0.03
Net Tangible Assets	0.65	0.29	0.41	0.96	-0.19	0.18	0.18	0.68	0.18	0.18	0.34	0.42	0.68	-0.26	0.65	0.11	0.41	-0.01	0.0	-0.04	-0.13		0.61	-0.31	0.36	0.61
Good Will	0.12	0.13	0.0	0.58	-0.49	-0.01	0.46	0.15	0.11	-0.03	0.27	-0.08	0.13	-0.18	0.06	0.35	-0.1	-0.08	-0.05	-0.06	0.03	0.61		-0.12	0.19	1.0
Retained Earnings Total Equity	-0.65	-0.84	-0.78	-0.3	-0.6	-0.79	0.35	-0.63	-0.95	-0.71	-0.95	-0.63	-0.63	0.98	-0.7	-0.68	-0.59	-0.6	-0.59	-0.69	-0.81	-0.31	-0.12		-0.94	-0.12
Capital Surpluse	0.66	0.84	0.76	0.44	0.51	0.77	-0.28	0.65	0.87	0.69	0.89	0.62	0.65	-0.93	0.68	0.62	0.58	0.54	0.53	0.61	0.7	0.36	0.19	-0.94		0.19
Intangible Assets	0.12	0.13	0.0	0.58	-0.49	-0.01	0.46	0.15	0.11	-0.03	0.27	-0.08	0.13	-0.18	0.06	0.35	-0.1	-0.08	-0.05	-0.06	0.03	0.61	1.0	-0.12	0.19

Click cells to compare fundamentals

MEI Pharma Account Relationship Matchups

MEI Pharma fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	174.1M	177.8M	120.8M	41.4M	47.6M	62.7M
Other Current Liab	7.5M	9.9M	11.0M	5.2M	6.0M	3.9M
Total Current Liabilities	30.3M	24.4M	20.3M	8.4M	9.6M	8.3M
Total Stockholder Equity	41.4M	52.4M	24.6M	33.0M	38.0M	32.7M
Net Debt	(245K)	(6.1M)	(4.2M)	(3.7M)	(4.3M)	(4.5M)
Accounts Payable	6.4M	7.9M	6.1M	3.2M	3.6M	2.2M
Cash	8.5M	15.7M	16.9M	3.7M	3.3M	3.2M
Cash And Short Term Investments	153.4M	153.3M	100.7M	38.3M	44.1M	57.3M
Common Stock Shares Outstanding	5.7M	6.3M	6.7M	6.7M	7.7M	8.0M
Liabilities And Stockholders Equity	174.1M	177.8M	120.8M	41.4M	47.6M	62.7M
Other Current Assets	3.8M	7.7M	11.3M	2.4M	2.8M	1.9M
Other Stockholder Equity	369.2M	426.6M	430.6M	421.2M	484.4M	508.6M
Total Liab	132.7M	125.4M	96.2M	8.4M	9.6M	9.1M
Total Current Assets	164.8M	167.1M	107.5M	40.8M	46.9M	60.9M
Retained Earnings	(327.8M)	(374.2M)	(406.0M)	(388.2M)	(349.4M)	(331.9M)
Short Term Investments	144.9M	137.5M	83.8M	34.6M	39.8M	70.4M
Property Plant And Equipment Net	9.3M	10.7M	13.3M	606K	696.9K	662.1K
Non Current Assets Total	9.3M	10.7M	13.3M	606K	696.9K	662.1K
Property Plant And Equipment Gross	9.3M	11.4M	14.3M	2.4M	2.7M	2.9M
Property Plant Equipment	1.1M	9.3M	10.7M	13.3M	15.3M	16.0M
Net Tangible Assets	78.2M	41.4M	52.4M	24.6M	28.3M	48.6M
Non Currrent Assets Other	(1.1M)	(9.3M)	(10.7M)	(13.3M)	(12.0M)	(11.4M)
Current Deferred Revenue	14.8M	14.6M	4.8M	317K	364.6K	346.3K
Net Invested Capital	41.4M	52.4M	24.6M	33.0M	29.7M	37.9M
Net Working Capital	134.5M	142.7M	87.2M	32.4M	37.3M	35.4M
Other Liab	108.2M	95.1M	92.2M	64.5M	74.2M	78.2M
Net Receivables	20.4M	7.6M	10.0M	85K	76.5K	72.7K

Additional Tools for MEI Stock Analysis

When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MEI Net Income vs Income Tax Expense Analysis

Net Income vs Income Tax Expense

Net Income vs Income Tax Expense Correlation Analysis

Correlation Coefficient

Net Income

Income Tax Expense

MEI Pharma fundamental ratios Correlations

MEI Pharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MEI Pharma fundamental ratios Accounts

Additional Tools for MEI Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Non Current Liabilities Total	+ 1.0	Total Liab
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Intangible Assets	+ 1.0	Good Will

Retained Earnings	- 0.96	Other Stockholder Equity
Retained Earnings Total Equity	- 0.95	Other Stockholder Equity
Retained Earnings Total Equity	- 0.95	Common Stock Shares Outstanding
Retained Earnings	- 0.95	Common Stock Shares Outstanding
Capital Surpluse	- 0.94	Retained Earnings Total Equity
Capital Surpluse	- 0.93	Retained Earnings